Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.646 +0.306 (+9.15%)
Streaming Delayed Price Updated: 2:12 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Horizon Therapeutics Stock Flashes Improved Technical Strength; Nears Buy Point ↗
Horizon Therapeutics stock had its Relative Strength Rating upgraded to 75 -- a welcome improvement, but still shy of the 80 or better score you look for. 
Via Investor's Business Daily
News headline image
Biotech Zai Lab Stock Sees Relative Strength Rating Jump To 83 ↗
A Relative Strength Rating upgrade for ZaiLabLimited shows improving technical performance. 
Via Investor's Business Daily
News headline image
Stock Market Rally Struggles With Inflation Spike; Tesla Sales Fall, Elon Musk Turns On Bitcoin As Coinbase Reports ↗
The market rally tested key levels as inflation fears mounted. Tesla's China sales dived as CEO Elon Musk dissed Bitcoin. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For May 10, 2021 ↗
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
News headline image
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2021 Earnings Call Transcript ↗
MRVI earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
IPO Stock Maravai Lifesciences Crushes First-Quarter Forecasts ↗
Late Monday, Maravai reported adjusted income of 26 cents per share on $148.21 million in sales. But the fresh IPO stock was unmoved in after-hours trading. 
Via Investor's Business Daily
Topics Initial Public Offering
News headline image
Coronavirus Vaccine Plays Moderna, Maravai, West Pharmaceutical Among 5 Stocks Near Buy Points ↗
Coronavirus vaccine maker Moderna and vaccine suppliers Maravai and West Pharmaceutical are among five stocks near buy points. 
Via Investor's Business Daily
Topics Supply Chain
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.